Get started today

Medicinal Cannabis & PTSD

Presented by Professor Kylie O'Brien, PhD. 
Write your awesome label here.

About this module:

In this presentation, Professor Kylie O’Brien PhD examines the topic of post-traumatic stress disorder (PTSD), including its signs and symptoms, pathophysiology, how the endocannabinoid system is involved, and scientific evidence for mechanisms of action and efficacy of medicinal cannabis in the treatment of PTSD. 

This presentation is a deep dive into the science and is suitable for healthcare practitioners and those with a background in biomedical sciences.

It assumes a knowledge of the endocannabinoid system and medicinal cannabis pharmacodynamics.
Learning Outcomes

At the end of this module, learners will be able to:

  • Describe the signs and symptoms associated with PTSD.
  • Describe the pathophysiology of PTSD.
  • Describe how the endocannabinoid system is involved in PTSD.  
  • Debate why medicinal cannabis and key phytocannabinoids may be efficacious in treating PTSD based on research evidence of mechanisms of action.
  • Critique the available evidence on efficacy of medicinal cannabis in treating PTSD, identifying current gaps in research. 

Professor Kylie O'Brien, PhD

Professor Kylie O’Brien PhD is an Adjunct Professor at Torrens University. She has a strong academic career in the fields of Chinese medicine, integrative medicine and, after a career change in 2000; medicinal cannabis. She has worked for the Victorian Department of Human Services, and held senior leadership roles in the university and private education sector. An internationally recognised expert in Chinese medicine and integrative medicine, she has published extensively, including a book on integrative oncology (US: Springer, 2017). Kylie’s second book – on mental health and medicinal cannabis – is due for publication in 2020. She is a member of the TGA Advisory Committee for Complementary Medicines and a TEQSA Expert Panel.

Kylie has been leading doctor education on medicinal cannabis in Australia since 2018. Her courses were the first to receive RACGP Category 1 CPD accreditation. She also set up the pathway via the National Institute of Integrative Medicine Ethics Committee for doctors to apply to become authorised prescribers of medicinal cannabis under the TGA’s Authorised Prescriber Scheme.
Created with